IPOs
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
Sources said the Atlanta-based InsurTech is likely to explore a dual track, with a potential sale looked at alongside the IPO.
-
Personal lines underperform predictions, while brokers and InsurTechs are a positive surprise (for now).
-
The proceeds will be used by the Bermudian to take advantage of rate hardening in key markets.
-
After pricing below the expected range at its IPO, the Fidelis stock price slipped on the first day of trading - here's how other (re)insurance IPOs have gone since 2000.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
The carrier has set its IPO price at between $16 and $19 per common share, and will trade on the New York Stock Exchange under the ticker FIHL.
-
Inside P&C’s news team runs you through the key highlights of the week.
-
The group’s returns have been driven by Two Sigma, but the total return model is perceived as toxic.
-
The Canadian investment company sold 3.85 million shares of common stock, priced at $23 per share.
Related
-
Aspen files F-1 with SEC confirming 2025 IPO optionality
December 11, 2024 -
The jammed PE conveyor belt: Broking’s $200bn+ of trapped capital
December 11, 2024 -
Aspen revs up IPO preparations again to give Q1 optionality
October 22, 2024 -
Accelerant rekindles IPO work with Q1 2025 launch target
September 23, 2024 -
Core Specialty sets wheels in motion on New York IPO
August 29, 2024